Isoniazid hepatitis: are immunological mechanisms implicated?
Martínez-Tadeo
J A
JA
González-Pérez
R
R
Hernández-Santana
G
G
D015746:Abdominal Pain; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D005334:Fever; D006505:Hepatitis; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects* / Q000627:therapeutic use; D009169:Mycobacterium tuberculosis / Q000276:immunology* / Q000472:pathogenicity; D020127:Recovery of Function; D012882:Skin Tests; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D028761:Withholding Treatment; D055815:Young Adult
D000305:Adrenal Cortex Hormones; D007538:Isoniazid